Showing results (781-790 of 809) with videos related to

Sort By:
Pageof 81
Journal of Pediatric Surgery|March 28, 2026
Pediatric Firearm Risk Prediction in Trauma Centers and After Discharge: A Machine Learning AnalysisCraig D Newgard, Sean Babcock, Amber Lin, et al.
Therapeutic Advances in Medical Oncology|February 9, 2023
Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2-, node-positive, high-risk early breast cancerShani Paluch-Shimon, Patrick Neven, Jens Huober, et al.
Journal of Cardiovascular Development and Disease|November 10, 2022
Genetic Profile and Clinical Characteristics of Brugada Syndrome in the Chinese PopulationLin-Lin Wang, Yang-Hui Chen, Yang Sun, et al.
Journal of Digestive Diseases|April 30, 2021
CD8<sup>+</sup> T cells actively penetrate hepatocytes via the CD44/p-ERM/F-actin pathway in autoimmune hepatitisJu Bo Liang, Yong Chen, Rui Ling Chen, et al.
Nature Communications|July 24, 2024
Uncovering the phonon spectra and lattice dynamics of plastically deformable InSe van der Waals crystalsJiangtao Wu, Yifei Lin, Mingfang Shu, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|July 18, 2020
<i>Anaplasma platys</i>-Like Infection in Goats, Beijing, ChinaWei Wei, Jie Li, Ya-Wei Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 11, 2022
Individualized Clinical Target Volume for Irradiation of the Supraclavicular Region in Breast Cancer Based on Mapping of the Involved Ipsilateral Supraclavicular Lymph NodesHao Jing, Yu Tang, Zong-Zhan Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2024
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy OutcomesPriya Rastogi, Joyce O'Shaughnessy, Miguel Martin, et al.
Nature Medicine|October 1, 2021
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumorsRachna T Shroff, Pavani Chalasani, Ran Wei, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer TherapyRachna T Shroff, Pavani Chalasani, Ran Wei, et al.
Pageof 81